FATE
Closed
Fate Therapeutics Inc
1.14
+0.02 (+1.79%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.12
Day's Range: 1.1 - 1.2
Send
sign up or login to leave a comment!
When Written:
5.7
Fate Therapeutics Inc. is a biopharmaceutical company that focuses on developing cell therapies for the treatment of cancer and other diseases. The company's proprietary platform technology, called induced pluripotent stem cell (iPSC) technology, enables the creation of cell-based therapies that can be used to treat a wide range of diseases.
Fate Therapeutics was founded in 2007 and is headquartered in San Diego, California. The company has a number of ongoing clinical trials for its cell therapies, including treatments for acute myeloid leukemia, solid tumors, and immune disorders.
In addition to its iPSC technology, Fate Therapeutics also has a number of other proprietary technologies and platforms, including gene editing and cell programming technologies. The company has partnerships with a number of other biopharmaceutical companies and research institutions to further develop its cell therapies.
Fate Therapeutics is a publicly traded company and is listed on the NASDAQ under the ticker symbol FATE.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Fate Therapeutics was founded in 2007 and is headquartered in San Diego, California. The company has a number of ongoing clinical trials for its cell therapies, including treatments for acute myeloid leukemia, solid tumors, and immune disorders.
In addition to its iPSC technology, Fate Therapeutics also has a number of other proprietary technologies and platforms, including gene editing and cell programming technologies. The company has partnerships with a number of other biopharmaceutical companies and research institutions to further develop its cell therapies.
Fate Therapeutics is a publicly traded company and is listed on the NASDAQ under the ticker symbol FATE.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








